Moreover, another group utilized combined KO of PD-1, endogenous T-cell receptor (TCR) alpha chain (TRAC), and beta-2 microglobulin (B2M) to enhance survival in a GBM xenografted mouse model [117]. Here, B2M is linked to glioblastoma.